Phase IV Study of the Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-Economic Comparison of Daptomycin vs Vancomycin Based Regimens.

Trial Profile

Phase IV Study of the Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-Economic Comparison of Daptomycin vs Vancomycin Based Regimens.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 23 Nov 2015

At a glance

  • Drugs Daptomycin (Primary) ; Vancomycin
  • Indications Diabetic foot ulcer; Gram-positive infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jun 2011 Actual initiation date (Aug 2010) added as reported by ClinicalTrials.gov.
    • 27 Jun 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 05 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top